Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Soichiro Funaki is a leading thoracic surgeon whose research focuses on the surgical management of thymic epithelial tumors and advanced radiotherapy for metastatic lung disease. His most impactful work, "Surgical treatment strategies for invasive thymoma" (2020, 27 citations), provides critical clinical data on managing this rare anterior mediastinal tumor, addressing the challenge of lower morbidity compared to other thoracic malignancies. Complementing this, his 2020 study on surgical management of thymic epithelial tumors (23 citations) has become a foundational reference in the field. Dr. Funaki has also pioneered the use of stereotactic ablative body radiotherapy (SABR) with CyberKnife for metastatic lung tumors (2023, 7 citations), demonstrating how robotically-positioned linear accelerators can deliver steep dose gradients and high central doses to improve treatment precision. His 2024 work on calcification as a predictor of thymoma invasion into adjacent organs (3 citations) offers a novel, non-invasive prognostic tool. Notably, Dr. Funaki contributed to the 2024 Japan Lung Cancer Society Medical Practice Guidelines for lung cancers and thymic tumors, shaping national standards for thymic epithelial tumor treatment. His research bridges surgical innovation and evidence-based practice, making significant strides in improving outcomes for patients with rare thoracic malignancies.